An investigational therapy is demonstrating preclinical promise against non-Hodgkin lymphoma by boosting natural killer cells ...

After sharing his cancer story online, Jace Yawnick is in a state of technical remission after receiving a diagnosis of non-Hodgkin lymphoma at age 25.

He further explained he was diagnosed with a slow-growing "bone marrow cancer" called Waldenström's macroglobulinemia (WM): ...

Rachel Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with ...

Global Refractory Follicular Lymphoma Diagnostics Market Projected to Reach USD 464.47 Million by 2029 Refractory Follicular ...

Donald Bell, a 74-year-old gay Black man who is co-chair of the Illinois Commission on LGBTQ Aging, lives alone in a studio apartment in subsidized LGBTQ+-friendly senior housing in Chicago. He spent ...

A haematologist shares insights into the challenges of the disease and the promise of emerging treatment options.

Irvine, California Monday, December 23, 2024, 18:00 Hrs [IST] ...

Diffuse large B-cell lymphoma is the most common type of lymphoma. It makes up approximately 25% of all non-Hodgkin’s lymphomas, which are cancers that lack defining cells called Hodgkin cells ...

The biotech company, which has dual headquarters in Seattle and Houston, adds to a $60 million Series A round it closed last ...

Recent research bolsters the case that radiotherapy to treat primary endometrial cancer is associated with an increased risk ...

DZD8586 demonstrated encouraging anti-tumor activity with manageable safety and favorable pharmacokinetic (PK) ...